Hepatitis A and typhoid vaccine

Hepatitis A and typhoid vaccine
Combination of
Hepatitis AVaccine
TyphoidVaccine
Names
Trade namesViVaxim, Hepatyrix, ViATIM
Clinical data
Pregnancy
category
  • AU: B2
    Routes of
    use    		Intramuscular injection
    External links
    AHFS/Drugs.comUK Drug Information
    US NLMHepatitis A and typhoid vaccine
    Legal
    Legal status
    • AU: S4 (Prescription only)
    Identifiers
    CAS Number
    • 827024-58-8 checkY
    ChemSpider
    • none
    ATC code

    Hepatitis A and typhoid vaccine is a combination vaccine to protect against hepatitis A and typhoid.[1]

    Formulation

    It is a combination of inactivated Hepatitis A virus and Vi polysaccharide of Salmonella typhi bacteria.

    Society and culture

    Brand names

    The vaccine is distributed under various brand names in the European Union.[1] Branded formulations include Hepatyrix from GlaxoSmithKline,[1][2] and ViVaxim[3][4][5][6][7] and ViATIM[8] from Sanofi Pasteur.[1][9]

    References

    1. 1 2 3 4 List of nationally authorised medicinal products. Active substance(s): hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed) (PDF) (Report). European Medicines Agency (EMA). Archived (PDF) from the original on 19 October 2020. Retrieved 18 October 2020.
    2. ↑ "Hepatyrix. Package Leaflet:Information for the user" (PDF). Drugs.com. Archived (PDF) from the original on 15 July 2018. Retrieved 15 July 2018.
    3. ↑ "VIVAXIM suspension and solution for suspension for injection in pre-filled syringe". Drugs.com. Archived from the original on 15 July 2018. Retrieved 15 July 2018.
    4. ↑ "Australian Product Information – Vivaxim (Salmonella typhi Vi polysaccharide and hepatitis A virus antigen) Vaccine" (PDF). Archived from the original on 19 October 2020. Retrieved 18 October 2020.
    5. ↑ "Vivaxim Salmonella typhi vaccine; Hepatitis A vaccine". Archived from the original on 19 October 2020. Retrieved 18 October 2020.
    6. ↑ "Vivaxim 1mL injection syringe composite pack". Therapeutic Goods Administration (TGA). Archived from the original on 19 October 2020. Retrieved 18 October 2020.
    7. ↑ "Summary for ARTG Entry: 82745 Vivaxim 1mL injection syringe composite pack" (PDF). Therapeutic Goods Administration (TGA). Retrieved 18 October 2020.{{cite web}}: CS1 maint: url-status (link)
    8. ↑ "ViATIM suspension and solution for suspension for injection in pre-filled syringe". Drugs.com. Archived from the original on 15 July 2018. Retrieved 15 July 2018.
    9. ↑ "ViATIM suspension and solution for suspension for injection in pre-filled syringe - Summary of Product Characteristics (SmPC)". (emc). 3 September 2019. Archived from the original on 19 October 2020. Retrieved 18 October 2020.


    This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.